Valeant Submits HSR Filing Related to Proposed Allergan Deal

Valeant Pharmaceuticals International, Inc.

today announced it has filed a premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U.S. Federal Trade Commission (FTC) relating to the proposed acquisition of Allergan, Inc.

.